Search

Bone morphogenetic protein-4 (BMP-4), a member of the transforming growth factor-β superfamily, is capable of initiating differentiation of uncommitted mesenchymal cells into a chondro/osteogenic pathway. This study reports the effects of pentoxifylline (PTX), a nonspecific inhibitor of phosphodiesterases (PDEs), that causes elevation of the intracellular cyclic adenosine monophosphate (cAMP) level on the BMP-4-induced chondro/osteogenic differentiation of a mesenchymal cell line, C3H10T1/2; a bone marrow stromal cell line, ST2; and an osteoblastic cell line, MC3T3-E1. It was found that PTX enhanced BMP-4-induced chondro/osteogenic differentiation in C3H10T1/2 and ST2 cells. Similar effects were observed when adding dibutyryl-cAMP and forskolin. These results indicate that cAMP may potentiate the action of BMP-4 on osteoprogenitor cells, highlighting the possibility that PDE inhibitors could be used as therapeutic agents to enhance bone formation through this effect. [ABSTRACT FROM AUTHOR]

The Japan Aerospace Exploration Agency (JAXA) views the lunar lander SELENE-2 as the successor to the SELENE mission. In this presentation, the mission objectives of SELENE-2 are shown together with the present design status of the spacecraft. JAXA launched the Kaguya (SELENE) lunar orbiter in September 2007, and the spacecraft observed the Moon and a couple of small satellites using 15 instruments. As the next step in lunar exploration, the lunar lander SELENE-2 is being considered. SELENE-2 will land on the lunar surface and perform in-situ scientific observations, environmental investigations, and research for future lunar utilization including human activity. At the same time, it will demonstrate key technologies for lunar and planetary exploration such as precise and safe landing, surface mobility, and overnight survival. The lander will carry laser altimeters, image sensors, and landing radars for precise and safe landing. Landing legs and a precisely controlled propulsion system will also be developed. A rover is being designed to be able to travel over a wide area and observe featured terrain using scientific instruments. Since some of the instruments require long-term observation on the lunar surface, technology for night survival over more than 2 weeks needs to be considered. The SELENE-2 technologies are expected to be one of the stepping stones towards future Japanese human activities on the moon and to expand the possibilities for deep space science. [ABSTRACT FROM AUTHOR]

Background: The intima-media thickness (IMT) of the carotid artery, as determined by ultrasonography, is useful for reflecting the extent of subclinical atherosclerosis. We investigated the relationship between IMT and the serum concentrations of small low-density lipoprotein (LDL) in diabetic patients. Methods: The study was conducted with 27 Type 2 diabetic patients (14 males and 13 females; mean age=62.6+/-8.3 years) and 12 age-matched healthy controls. The LDL subfraction was measured using a polyacrylamide gel electrophoresis method. Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) concentrations were measured by an enzyme immunoassay. The IMT was expressed as the maximum IMT (Max-IMT) and average IMT (Ave-IMT) of the carotid artery, measured by ultrasonography. Results: Both the IMT and the small LDL concentrations were significantly increased in the diabetic patients compared with the healthy participants. The IMTs were significantly correlated with small LDL concentration and small LDL/total LDL more than LDL concentrations by multivariate analysis. The IMTs were not significantly correlated with the serum VEGF or PDGF concentrations. The patients with a larger IMT had a significantly higher prevalence of hypertension or ischemic heart disease than did the patients with a normal IMT. Conclusions: The increased small LDL concentrations and small LDL/total LDL, in addition to total LDL concentrations, in Type 2 diabetic patients are closely associated with increased IMT of the carotid artery. [ABSTRACT FROM AUTHOR]

Collagen sponge disks (6 mm diameter, 1 mm thickness) were impregnated with recombinant human bone morphogenetic protein-2 (rhBMP-2) (5 μg/disk) and implanted onto the back muscles of mice. Ten or 20 mg/kg per day of Rolipram, a selective inhibitory agent to phosphodiesterase type 4 (PDE-4), or vehicle, was injected subcutaneously into the host mice for 3 weeks. After treatment, rhBMP-2-induced ectopic ossicles were harvested and examined by radiographic and histologic methods to determine the size, bone quality, and mineral content of the ossicles. The ossicles from a group treated with 20 mg/kg per day Rolipram were significantly larger in size and higher in bone mineral density (BMD) and bone mineral content (BMC) than the control samples. No significant differences were noted in mice treated with 10 mg/kg per day of Rolipram. Histologically, ossicles from the high-dose (20 mg/kg per day) Rolipram-treated group showed densely packed, thicker trabeculae when compared with those from the control group. These experimental results indicate that the PDE-4 inhibitor, Rolipram, may enhance the bone-inducing capacity of BMP-2 in mesenchymal cells. This in turn may result in increased responsiveness to BMP-2 and point to a potential use of PDE-4 inhibitors for the promotion of rhBMP-dependent bone repair. [ABSTRACT FROM AUTHOR]

Introduction/Background While previous studies have reported that unilateral spatial neglect (USN) and pusher syndrome are related but independent symptoms, their relationship has not been investigated using a quantitative scale and causative lesions using brain imaging. This study aimed to clarify the relationship between evaluation scores and the extent of the damaged area revealed by brain imaging. Material and method We evaluated twenty patients with first-ever stroke and pusher syndrome (14 right and 6 left hemispheric patients). First, we analyzed the relationship between the Catherine Bergego Scale (CBS) and Scale for Contraversive Pushing (SCP). We also introduced a new way of quantifying the affected brain lesions at two levels of horizontal brain imaging slice. At each level, a brain hemisphere was divided into 3 areas, and the total number of damaged areas from these two levels was used as an indication of the extent of the damaged lesion, ranging 0 to 6 ( Fig. 1 ). By using this score, the relationship between the CBS and SCP scores was further examined. Results All patients with pusher syndrome had USN based on CBS. In each subject, the CBS score was positively correlated with the SCP score (Spearman = 0.805, P < 0.001) ( Fig. 2 ). Brain imagining showed that six patients had damage in both slice 1 and slice 2, while the fourteen patients had damage only in slice 2. The imaging score at slice 1 was correlated with the CBS score in the first group. Conclusion The severity of USN was positively correlated with that of pusher syndrome with clinical scales. The location and extent of the damaged area in relation to SCP and CBS needs to be examined with a larger sample size in future. [ABSTRACT FROM AUTHOR]